CORC

浏览/检索结果: 共22条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: a cross-sectional study in China 期刊论文
2019, 卷号: 9, 期号: 5, 页码: e028589
作者:  Jiang, Shiyu;  Liu, Peng;  Yang, Sheng;  Yang, Jianliang;  Wu, Dawei
收藏  |  浏览/下载:10/0  |  提交时间:2020/01/03
Promising efficacy of SHR-1210, a novel anti-programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China 期刊论文
2019, 卷号: 125, 期号: 5, 页码: 742-749
作者:  Huang, Jing;  Mo, Hongnan;  Zhang, Weilong;  Chen, Xuelian;  Qu, Dong
收藏  |  浏览/下载:21/0  |  提交时间:2020/01/03
Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody 期刊论文
2019, 卷号: 10, 期号: 6, 页码: 1395-1401
作者:  Wang, Xi;  Zhang, Bo;  Chen, Xuelian;  Mo, Hongnan;  Wu, Dawei
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210 期刊论文
2019, 卷号: 16, 期号: 1, 页码: 173-+
作者:  Chen, Xuelian;  Ma, Lanying;  Wang, Xi;  Mo, Hongnan;  Wu, Dawei
收藏  |  浏览/下载:7/0  |  提交时间:2020/01/03
Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma 期刊论文
2018, 卷号: 24, 期号: 6, 页码: 1296-1304
作者:  Huang, Jing;  Xu, Binghe;  Mo, Hongnan;  Zhang, Weilong;  Chen, Xuelian
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/03
Safety, anti-tumour activity, and pharmacokinetics of fixed- dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study 期刊论文
2018, 卷号: 119, 期号: 5, 页码: 538-545
作者:  Mo, Hongnan;  Huang, Jing;  Xu, Jiachen;  Chen, Xuelian;  Wu, Dawei
收藏  |  浏览/下载:15/0  |  提交时间:2020/01/03
Red blood cell distribution width as a related factor of pulmonary arterial hypertension in patients with systemic sclerosis 期刊论文
2018, 卷号: 37, 期号: 4, 页码: 979-985
作者:  Zhao, Jiuliang;  Mo, Hongnan;  Guo, Xiaoxiao;  Wang, Qian;  Xu, Dong
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/03
Targeting MET in cancer therapy 期刊论文
2017, 卷号: 3, 期号: 3, 页码: 148-153
作者:  Mo Hongnan;  Liu Peng
收藏  |  浏览/下载:8/0  |  提交时间:2020/01/03
Phase I study of the anti-PD-1 antibody SHR-1210 in patients with advanced solid tumors. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Huang, Jing;  Mo, Hongnan;  Wu, Dawei;  Chen, Xuelian;  Ma, Lanying
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/04
Phase I study of the anti-PD-1 antibody SHR-1210 in patients with advanced solid tumors. 期刊论文
2017, 卷号: 35
作者:  Huang, Jing;  Mo, Hongnan;  Wu, Dawei;  Chen, Xuelian;  Ma, Lanying
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/04


©版权所有 ©2017 CSpace - Powered by CSpace